According to the...CDC..., myocarditis/pericarditis rates are ≈12.6 cases per million doses of second-dose mRNA vaccine among individuals 12 to 39 years of age.....
For age group 12-24 according to table 1, I get about 55 cases per million observed. Adding in the 25-39 year cohort brought the average down. Apparently, they gleaned these numbers from VAERS.
* .....Preliminary myocarditis/pericarditis reports to US... VAERS after dose-2 mRNA vaccination, expected vs observed number of cases using 7-day risk window with data through June 11, 2021.,,,,
The vaccine rollout didn’t get to the 12-39 yo cohort until late in the game. So through June 11, they have about 3 months of VAERS data.
Considering VAERS data is underreported (I’ve read from a factor of anywhere from 10 - 40 to 1) and that the data here is from early in the vaccination effort, I’m skeptical that the 12.6 cases per million doses is still holding up today.
I agree.
This report and data does not show that everyone older than 12 is safe from mRNA vaccine caused myocarditis.
That is a very different conclusion, and not supported.